Liposomal Bupivacaine To Control Post-Operative Pain Following BMG

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03720223

Recruitment Status : Unknown

Verified October 2018 by Urology of Virginia.
Recruitment status was: Active, not recruiting

First Posted : October 25, 2018

Last Update Posted : October 26, 2018

Sponsor:

Information provided by (Responsible Party):

Urology of Virginia

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	December 31, 2018
Estimated Study Completion Date :	December 31, 2018

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Chua ME, Zuckerman JM, Strehlow R 6th, Virasoro R, DeLong JM, Tonkin J, McCammon KA. Liposomal Bupivacaine Local Infiltration for Buccal Mucosal Graft Harvest Site Pain Control: A Single-blinded Randomized Controlled Trial. Urology. 2020 Nov;145:269-274. doi: 10.1016/j.urology.2020.06.067. Epub 2020 Jul 18.

To Top